ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-13G16055
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global and India Amyotrophic Lateral Sclerosis ALS Treatment Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Report & Forecast 2023-2029

Code: QYRE-Auto-13G16055
Report
November 2023
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma

and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size

The global Amyotrophic Lateral Sclerosis (ALS) Treatment revenue was US$ 300 million in 2022 and is forecast to a readjusted size of US$ 520.8 million by 2029 with a CAGR of 8.1% during the review period (2023-2029).

and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market

and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
In India, the Amyotrophic Lateral Sclerosis (ALS) Treatment revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.
North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent.
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.
This report focuses on global and India Amyotrophic Lateral Sclerosis (ALS) Treatment market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Amyotrophic Lateral Sclerosis (ALS) Treatment will continue to grow rapidly in the future.
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis (ALS) Treatment market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (ALS) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Amyotrophic Lateral Sclerosis (ALS) Treatment market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Report

Report Metric Details
Report Name and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market
Forecasted market size in 2029 US$ 520.8 million
CAGR 8.1%
Forecasted years 2023 - 2029
Segment by Type
  • Riluzole
  • Edaravone (Radicava)
  • Other
Segment by Application
  • Hospital
  • Drugs Store
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market size in 2029?

Ans: The and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market size in 2029 will be US$ 520.8 million.

What is the market share of major companies in and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market?

Ans: Global top two manufacturers hold a share over 80%.

What is the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market share by type?

Ans: In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%.

What is the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market report?

Ans: The main players in the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market are Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma

What are the Application segmentation covered in the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market report?

Ans: The Applications covered in the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market report?

Ans: The Types covered in the and India Amyotrophic Lateral Sclerosis (ALS) Treatment Market report are Riluzole, Edaravone (Radicava), Other

1 Study Coverage
1.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Introduction
1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Outlook 2018 VS 2022 VS 2029
1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size for the Year 2018-2029
1.2.2 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size for the Year 2018-2029
1.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Amyotrophic Lateral Sclerosis (ALS) Treatment in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Dynamics
1.4.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Trends
1.4.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
1.4.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
1.4.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Amyotrophic Lateral Sclerosis (ALS) Treatment by Type
2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Type
2.1.1 Riluzole
2.1.2 Edaravone (Radicava)
2.1.3 Other
2.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018, 2022 & 2029)
2.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2029)
2.4 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018, 2022 & 2029)
2.5 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2029)
3 Amyotrophic Lateral Sclerosis (ALS) Treatment by Application
3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Drugs Store
3.1.3 Other
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018, 2022 & 2029)
3.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2029)
3.4 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018, 2022 & 2029)
3.5 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2029)
4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Competitor Landscape by Company
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Company
4.1.1 Global Key Companies of Amyotrophic Lateral Sclerosis (ALS) Treatment, Ranked by Revenue (2022)
4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Player (2018-2023)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Concentration Ratio (CR)
4.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Amyotrophic Lateral Sclerosis (ALS) Treatment in 2022
4.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment Head office and Area Served
4.4 Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Product and Application
4.5 Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Company
4.7.1 Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment in India, Ranked by Revenue (2022)
4.7.2 India Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2021, 2022 & 2023)
5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2018-2029)
5.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region: 2018-2023
5.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2024-2029)
6 Americas
6.1 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth 2018-2029
6.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
6.2.1 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023)
6.2.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029)
6.2.3 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
6.3 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
6.3.1 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023)
6.3.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029)
6.3.3 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
6.4 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth 2018-2029
7.2 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
7.2.1 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023)
7.2.2 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029)
7.2.3 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
7.3 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
7.3.1 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023)
7.3.2 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029)
7.3.3 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
7.4 EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth 2018-2029
8.2 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
8.2.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023)
8.2.2 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029)
8.2.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
8.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
8.3.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023)
8.3.2 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029)
8.3.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth 2018-2029
9.2 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
9.2.1 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023)
9.2.2 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029)
9.2.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
9.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
9.3.1 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023)
9.3.2 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029)
9.3.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
9.4 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Mitsubishi Tanabe Pharma
10.1.1 Mitsubishi Tanabe Pharma Company Details
10.1.2 Mitsubishi Tanabe Pharma Business Overview
10.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.1.5 Mitsubishi Tanabe Pharma Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Details
10.2.2 Sanofi Business Overview
10.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.2.5 Sanofi Recent Development
10.3 Mylan Pharma
10.3.1 Mylan Pharma Company Details
10.3.2 Mylan Pharma Business Overview
10.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.3.5 Mylan Pharma Recent Development
10.4 Apotex
10.4.1 Apotex Company Details
10.4.2 Apotex Business Overview
10.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.4.5 Apotex Recent Development
10.5 Glemark Generics
10.5.1 Glemark Generics Company Details
10.5.2 Glemark Generics Business Overview
10.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.5.5 Glemark Generics Recent Development
10.6 Covis Pharma
10.6.1 Covis Pharma Company Details
10.6.2 Covis Pharma Business Overview
10.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.6.5 Covis Pharma Recent Development
10.7 Sun Pharma
10.7.1 Sun Pharma Company Details
10.7.2 Sun Pharma Business Overview
10.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.7.5 Sun Pharma Recent Development
10.8 Lunan Pharma
10.8.1 Lunan Pharma Company Details
10.8.2 Lunan Pharma Business Overview
10.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
10.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
10.8.5 Lunan Pharma Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
List of Tables
    Table 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Trends
    Table 3. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
    Table 4. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
    Table 5. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
    Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Amyotrophic Lateral Sclerosis (ALS) Treatment, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Share by Player, 2018-2023
    Table 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Amyotrophic Lateral Sclerosis (ALS) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment as of 2022)
    Table 15. Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Headquarters and Area Served
    Table 16. Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Product and Application
    Table 17. Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Mitsubishi Tanabe Pharma Company Details
    Table 52. Mitsubishi Tanabe Pharma Business Overview
    Table 53. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 54. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 55. Mitsubishi Tanabe Pharma Recent Development
    Table 56. Sanofi Company Details
    Table 57. Sanofi Business Overview
    Table 58. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 59. Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 60. Sanofi Recent Development
    Table 61. Mylan Pharma Company Details
    Table 62. Mylan Pharma Business Overview
    Table 63. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 64. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 65. Mylan Pharma Recent Development
    Table 66. Apotex Company Details
    Table 67. Apotex Business Overview
    Table 68. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 69. Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 70. Apotex Recent Development
    Table 71. Glemark Generics Company Details
    Table 72. Glemark Generics Business Overview
    Table 73. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 74. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 75. Glemark Generics Recent Development
    Table 76. Covis Pharma Company Details
    Table 77. Covis Pharma Business Overview
    Table 78. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 79. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 80. Covis Pharma Recent Development
    Table 81. Sun Pharma Company Details
    Table 82. Sun Pharma Business Overview
    Table 83. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 84. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 85. Sun Pharma Recent Development
    Table 86. Lunan Pharma Company Details
    Table 87. Lunan Pharma Business Overview
    Table 88. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 89. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023) & (US$ Million)
    Table 90. Lunan Pharma Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture
    Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2018-2029 (US$ Million)
    Figure 4. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2018-2029 (US$ Million)
    Figure 6. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share in Global 2018-2029
    Figure 7. Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
    Figure 8. Product Picture of Riluzole
    Figure 9. Product Picture of Edaravone (Radicava)
    Figure 10. Product Picture of Other
    Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type in 2022 & 2029
    Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2029) & (US$ Million)
    Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
    Figure 14. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type in 2022 & 2029
    Figure 15. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2018-2029) & (US$ Million)
    Figure 16. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
    Figure 17. Product Picture of Hospital
    Figure 18. Product Picture of Drugs Store
    Figure 19. Product Picture of Other
    Figure 20. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application in 2022 & 2029
    Figure 21. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2029) & (US$ Million)
    Figure 22. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
    Figure 23. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application in 2022 & 2029
    Figure 24. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2018-2029) & (US$ Million)
    Figure 25. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
    Figure 26. The Top 5 and 10 Largest Companies of Amyotrophic Lateral Sclerosis (ALS) Treatment in the World: Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2022
    Figure 27. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 28. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2018-2029)
    Figure 29. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 30. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
    Figure 31. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
    Figure 32. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 36. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 37. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
    Figure 38. EMEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
    Figure 39. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Middle East Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 42. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 43. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
    Figure 44. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
    Figure 45. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 46. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2018-2029)
    Figure 47. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2018-2029)
    Figure 48. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 49. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 50. China Taiwan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 54. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 55. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 56. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 57. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 58. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 59. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 60. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2018-2023)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Amyotrophic Lateral Sclerosis Gene Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4R20263
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Online Speech Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39V19943
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Nerve Repair and Regeneration Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10C17235
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Neurological Disease Model Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-7M17348
Thu Nov 06 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions